Bloomberg Surveillance TV: March 28, 2024
Bloomberg Surveillance
00:00
Innovative Drug Approval for Pulmonary Arterial Hypertension
Exploration of the approval of Winrever, a novel biologic drug with a unique mechanism to address pulmonary arterial hypertension, alongside the importance of diversifying research to tackle rare diseases affecting specific demographics.
Transcript
Play full episode
